** Drugmaker GlaxoSmithKline down 3 percent, hit by trading ex-dividend and downgrade to "neutral" from "buy" by brokerage UBS (NYSEArca: FBGX - news) ** UBS analyst Alexandra Hauber says GSK's 2020 pharma outlook implies …
Analysts led by Christopher Wheeler of Mediobanca in a recent note to clients believe these events have resulted in UBS dusting off plans for disposing of the investment bank. The analysts ... a London-based firm with stock traded in the …
Here’s a ridiculous story for a Friday afternoon. Swiss banking giant UBS placed a $31 billion, or 3 trillion yen, order for convertible bonds in the Japanese game publisher Capcom. The deal would have been the biggest ever on the Tokyo …
In a note to clients, UBS analyst Steven Milunovich provided his revenue estimate of $75.6 billion for Apple’s Q116 (December quarter) is below the analysts’ consensus and also near the low end of the company’s guidance. In …
UBS appears to be having a hard time keeping out of the news. Less than a month after reaching a settlement with the US government over a probe into client tax evasion the bank finds itself under the spotlight again. The Swiss stock …
The company’s stock fell 11% on the news. UBS warned that its third quarter probably would be unprofitable, although analysts say the bank – Switzerland’s largest – should be able to absorb the loss. Previously UBS had forecast a profit …
Ferrari SpA, the ultra-luxury sports car manufacturer being spun off by its parent Fiat Chrysler Automobiles into an independent company, will use UBS Group AG to manage its upcoming New York stock initial public offering. The …
BlackRock has added UBS' Daniel Whitestone to boost its small- and mid-cap stock team. Whitestone will serve as an analyst for BlackRock's UK Emerging Companies hedge fund initially. He was head of U.K. small- and mid-cap sales at …
UBS says Western Areas is fast approaching debt-free status and has the ability to maintain consistent dividends, which is not a bad position to be in for a resources company now. UBS says Western Areas is fast approaching debt-free …
UBS Securities upgraded its rating on shares of Baker Hughes Inc. (NYSE: BHI) to buy from neutral and increased its price target to $87 from $73. The stock touched a new 52-week high of $72.40 during Thursday's early trade. We are …